Tickerplace logo

Tickerplace

Regeneron Pharmaceuticals, Inc. logo

REGNRegeneron Pharmaceuticals, Inc.

REGN Stock Price, Valuation & Chart | Regeneron Pharmaceuticals, Inc.

Compare
$828.50-5.54 (-0.66%)

At close · 24 Aug 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyREGN intrinsic valueIs REGN overvalued or undervalued
OverviewFinancialsDividendsRatios

REGN Historical price chart

REGN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization85.35B
PE Ratio18.16
EPS45.63
Trading Volume717.67K
Today's High/Low834.7/823.39
Dividend Yield0.45
52 Week High/Low847.0/541.0
Shares Outstanding103.02M
REGN Financial Statement
REGN Analyst ratings
REGN Analysis & performance metrics

REGN Company profile

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products…

REGN Management team

Management
Leonard S. Schleifer M.D., Ph.D.CEO
Co-Founder, President, Chief Executive Officer & Co-Chairman
Bob McCowanCTO
Senior Vice President of IT & Chief Information Officer
Melissa Lozner
Senior Vice President & Chief Compliance Officer
Patrice Gilooly
Senior Vice President of Quality Assurance & Operations
Ryan Crowe
Senior Vice President of Investor Relations & Strategic Analysis
Christopher R. Fenimore CPACFO
Executive Vice President of Finance & Chief Financial Officer
Daniel P. Van Plew
Executive Vice President and GM of Industrial Operations & Product Supply
George D. Yancopoulos M.D., Ph.D.
Co-Founder, President, Chief Scientific Officer & Co-Chairman
Total 8 executives

REGN Frequently asked questions

What is Regeneron Pharmaceuticals, Inc. (REGN) Stock Price?

Current stock price of Regeneron Pharmaceuticals, Inc. (REGN) stock is $828.50. The stock price is -0.66% lower in the session. The intraday range can be seen from this page. Volume of Regeneron Pharmaceuticals, Inc. (REGN) stock is 717.67K.

Last updated at 24 Aug 2026, 08:00 pm.

Why is the Regeneron Pharmaceuticals, Inc. (REGN) stock price going up or down today?

The stock price of Regeneron Pharmaceuticals, Inc. (REGN) can change with earnings, company news, and overall market sentiment. Regeneron Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Regeneron Pharmaceuticals, Inc. stock expensive at its current price?

Whether Regeneron Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for REGN on this page is 18.16. EPS on this page is 45.63. Compare those figures with peers and growth expectations before deciding if the current Regeneron Pharmaceuticals, Inc. price is justified.

How has the stock price of Regeneron Pharmaceuticals, Inc. (REGN) performed historically?

Historical performance for Regeneron Pharmaceuticals, Inc. (REGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how REGN reacted to past earnings and market events.

Should I buy Regeneron Pharmaceuticals, Inc. (REGN) stock, at this price?

Buying Regeneron Pharmaceuticals, Inc. (REGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.